About Macrodeep
New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Raportul

Știri verificate despre finanțări, sedii centrale și leadership de la cele mai inovatoare companii din lume

22 rapoarte și mai multe

Actualizat zilnic cu ultimele informații de piață
Fundraising
OMass Therapeutics

OMass Therapeutics Raises $310M Series C for Small-Molecule Therapeutics

OMass Therapeutics raised an oversubscribed $310 million Series C co-led by Bain Capital Life Sciences, Forbion and Novo Holdings to advance its small molecule pipeline in endocrinology and immunology.

SalesTools Research
Oct 15, 2026
2 min read•$310M
Fundraising
Khartis Therapeutics

Khartis Therapeutics Raises $50M Series B for Oral Immunology Medicines

Khartis Therapeutics raised a $50 million Series B led by Forge Life Science Partners to advance its oral IGF-1R inhibitor for thyroid eye disease.

SalesTools Research
Aug 13, 2026
2 min read•$50M
Fundraising
Boulevard Bio

Boulevard Bio Launches With Approximately $65M From Deerfield for Precision Immunology

Boulevard Bio announced its emergence from stealth with approximately $65 million in aggregate financing from Deerfield and affiliates, provided in equity capital and convertible notes.

SalesTools Research
Aug 12, 2026
2 min read•$65M
Fundraising
Infinimmune

Infinimmune Raises $75M Series A for Human-Derived Antibody Drugs

Infinimmune raised a $75 million Series A co-led by Regeneron Ventures and Playground Global to advance human-derived antibody programs in atopic dermatitis and inflammatory disease.

SalesTools Research
Aug 11, 2026
2 min read•$75M
Leadership
Dualitas Therapeutics

Dualitas Therapeutics Appoints Karim Dabbagh Chief Executive Officer

Dualitas Therapeutics appointed Karim Dabbagh, formerly President and CEO of Silver Creek Pharmaceuticals, as Chief Executive Officer, with former interim CEO Rich Murray remaining on the Board of Directors.

SalesTools Research
Jun 8, 2026
2 min read
Pharmaceutical
Eli Lilly and Company

Eli Lilly and Company Headquarters - Office Location & Address

Discover Eli Lilly and Company's headquarters at 893 S Delaware St, Indianapolis, IN 46225. Pharmaceutical company discovering, developing, and marketing medicines for diabetes, oncology, immunology, and neuroscience. Leading provider of insulin and diabetes care with strong pipeline in oncology and immunology.. Learn about the office facilities and work environment.

Editorial Team
Oct 6, 2025
0 min read
Biotechnology
Electra Therapeutics

Electra Therapeutics Raises $183 Million in Series C - October 22, 2024

Electra Therapeutics announced $183 Million in Series C funding at a Undisclosed valuation. Electra Therapeutics raised an oversubscribed $183 million Series C to advance clinical trials for novel immunology therapies targeting autoimmune and...

James Rodriguez
Oct 26, 2025
0 min read•$183 Million
Biotech
Bambusa Therapeutics

Bambusa Therapeutics raises $90M Series A at $400M valuation

Bambusa Therapeutics raises $90M in Series A at $400M valuation. Bispecific antibodies for immunology...

Editorial Team
Feb 15, 2025
0 min read•$90M
HealthTech
Evommune

Evommune raises $50M Series B at $300M valuation

Evommune raises $50M in Series B at $300M valuation. Oral immunology treatments...

Editorial Team
Aug 1, 2025
0 min read•$50M
Pagina 1

Afișare 9 rapoarte • Pagina 1 • Categorie: all

Rămâneți înaintea pieței

Primiți perspective săptămânale în inbox. Fără spam, doar inteligență.